Massive programmed cell death in intestinal epithelial cells induced by three-dimensional growth conditions: Suppression by mutant c-H-ras oncogene expression

Journal of Cell Biology

Volumn 131, Issue 6 I, 1995, Pages 1587-1598

  Rak, Janusz ^b   Mitsuhashi, Yoshihiro ^b   Erdos, Victor ^b   Huang, Shao Nan ^b   Filmus, Jorge ^b   Kerbel, Robert S ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL GROWTH; GENE REPRESSION; GROWTH INHIBITION; GROWTH REGULATION; INTESTINE EPITHELIUM CELL; NEWBORN; NONHUMAN; ONCOGENE C H RAS; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; CELL ADHESION; EPITHELIAL CELLS; EPITHELIUM; GENE EXPRESSION REGULATION; INTESTINES; MUTATION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS P21(RAS); RATS; SPHEROIDS, CELLULAR; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0029562231     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.131.6.1587     Document Type: Article

References (91)

1. Arends, M. J., A. H. McGregor, N. J. Toft, E. J. H. Brown, and A. H. Wyllie. 1994. Susceptibility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availability. Br. J. Cancer. 68:1127-1133.
2. Barry, M. A., C. A. Behinke, and A. Eastman. 1990. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem.Pharmacol. 40:2353-2362.
3. Bates, R. C., A. Buret, D. F. van Helden, M. A. Horton, and G. F. Burns. 1994. Apoptosis induced by inhibition of intercellular contact. J. Cell Biol. 125:403-415.
4. Bedi, A., P. J. Pasricha, A. J. Akhtar, J. P. Barber, G. C. Bedi, F. M. Giardiello, B. A. Zehnbauer, S. R. Hamilton, and R. J. Jones. 1995. Inhibition of apoptosis during development of colorectal cancer. Cancer Res. 55: 1811-1816.
5. Boise, L. H., M. Gonzalez-Garcia, C. E. Postema, L. Ding, T. Lindsten, L. A. Turka, X. Mao, G. Nunez, and C. B. Thompson. 1993. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74:597-608.
6. Boudreau, N., C. J. Sympson, Z. Werb, and M. J. Bissell. 1995. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science (Wash. DC). 267:891-893.
7. Brooks, P. C., R. A. F. Clark, and D. A. Cheresh. 1994. Requirement of vascular integrin ανβ3 for angiogenesis. Science (Wash. DC). 264:569-572.
8. Brunet, A., G. Pages, and J. Pouyssegur. 1994. Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts. Oncogene. 9:3379-3387.
9. Buick, R. N., J. Filmus, and A. Quaroni. 1987. Activated H-ras transforms rat intestinal epithelial cells with expression of α-TGF. Exp. Cell Res. 170:300-309.
10. Bursch, W., B. Grasl-Kraupp, A. Ellinger, L. Torok, H. Kienzl, L. Mullauer, and R. Schulte-Hermann. 1994. Active cell death: role in hepatocarcinogenesis and subtypes. Biochem. Cell Biol. 72:669-675.
11. Canman, C. E., and M. B. Kastan. 1995. Induction of apoptosis by tumor suppressor genes and oncogenes. Semin. Cancer Biol. 6:17-25.
12. Chittenden, T., E. A. Harrington, R. O'Connor, C. Flemington, R. J. Lutz, G. I. Evan, and B. C. Guild. 1995. Induction of apoptosis by the Bcl-2 homologue Bak. Nature (Lond.). 374:733-736.
13. Cohen, G. M., X. M. Sun, and R. T. Snowden. 1992. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem. J. 286:331-334.
14. L by cytotoxic drug exposure confers resistance to ionizing radiation-induced internucleosomal DNA fragmentation. Cell Growth & Differ. 6:363-370.
15. Dole, M., G. Nunez, A. K. Merchant, J. Maybaum, C. K. Rode, C. A. Bloch, and V. P. Castle. 1994. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res. 54:3253-3259.
16. Eastman, A. 1990. Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells. 2:275-280.
17. Farrow, S. N., J. H. M. White, I. Martinou, T. Raven, K.-T. Pun, C. J. Grinham, J.-C. Martinou, and R. Brown. 1995. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature (Lond.). 374:731-733.
18. Fath, I., F. Schweighoffer, I. Rey, M. -C. Multon, J. Boiziau, M. Duchesne, and B. Tocque. 1995. Cloning of a grb2 isoform with apoptotic properties. Science 264:971.
19. Fearon, E. R., and B. Vogelstein. 1990. A genetic model for colorectal tumorigenesis. Cell. 61:759-767.
20. Fernandez, A., M. C. Marin, T. McDonnell, and H. N. Ananthaswamy. 1994. Differential sensitivity of normal and Ha-ras-transformed C3H mouse embryo fibroblasts to tumor necrosis factor: induction of bcl-2, c-myc, and manganese Superoxide dismutase in resistant cells. Oncogene. 9:2009-2017.
21. Ferrari, G., and L. A. Greene. 1994. Proliferative inhibition by dominant-negative Ras rescues naive and neuronally differentiated PC12 cells from apoptotic death. EMBO (Eur. Mol. Biol. Organ.) J. 13:5922-5928.
22. Filmus, J., A. I. Robles, W. Shi, M. J. Wong, L. L. Colombo, and C. J. Conti. 1994. Induction of cyclin D1 overexpression by activated ras. Oncogene. 9:3627-3633.
23. Filmus, J., J. Zhao, and R. N. Buick. 1992. Over-expression of H-ras oncogene induces resistance to the growth inhibitory action of TGF-β1 and alters the number and type of TGF-β1 receptors in rat intestinal epithelial cell clones. Oncogene. 7:521-526.
24. Fisher, D. E. 1994. Apoptosis in cancer therapy: crossing the threshold. Cell. 78:539-542.
25. Flouriot, G., C. Vaillant, G. Salbert, C. Pelissero, J. M. Guiraud, and Y. Valotaire. 1993. Monolayer and aggregate cultures of rainbow trout hepatocytes: long-term and stable liver-specific expression in aggregates. J. Cell Science. 105:407-416.
26. Freedman, V. H., and S. Shin. 1974. Cellular tumorgenicity in nude mice: correlation with cell growth in semi-solid medium. Cell. 3:335-360.
27. Frisch, S. M., and H. Francis. 1994. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124:619-626.
28. Gibbs, J. B., A. Oliff, and N. E. Kohl. 1994. Farnesyltransferase inhibitors: ras research yields a potential cancer therapeutic. Cell. 77:175-178.
29. Graham, C. H., H. Kobayashi, K. S. Stankiewicz, S. Man, S. J. Kapitain, and R. S. Kerbel. 1994. Rapid acquisition of multicellular drug resistance after a single transient exposure of mammary tumor cells to alkylating agents. J. Natl. Cancer Inst. 86:975-982.
30. Guadagno, T. M., M. Ohtsubo, J. M. Roberts, and R. K. Assoian. 1994. A link between cyclin A expression and adhesion-dependent cell cycle progression. Science (Wash. DC). 262:1572-1575.
31. Harris, A. L. 1994. Editorial: what does BCL-2 mean in solid tumours - friend or foe? Ann. Oncol. 5:388-390.
32. Hasegawa, H., M. Ueda, M. Watanabe, T. Teramoto, M. Mukai, and M. Kitajima. 1995. K-ras gene mutations in early colorectal cancer . . . flat elevated vs. polyp-forming cancer . . . Oncogene. 10:1413-1416.
33. Hermiston, M. L., and J. I. Gordon. 1995. In vivo analysis of cadherin function in the mouse intestinal epithelium: essential roles in adhesion, maintenance of differentiation, and regulation of programmed cell death. J. Cell Biol. 129:489-506.
34. Hickman, J. A. 1992. Apoptosis induced by anticancer drugs. Cancer Metastasis Rev. 11:121-139.
35. Hockenbery, D. M. 1994. bcl-2 in cancer, development and apoptosis. J. Cell Science. 18:51-55.
36. Hockenbery, D. M., Z. N. Oltvai, X. Yin, C. L. Milliman, and S. J. Korsmeyer. 1993. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75:241-251.
37. Jamal, H., D. F. Cano-gauci, R. N. Buick, and J. Filmus. 1994. Activated ras and src induce CD44 overexpression in rat intestinal epithelial cells. Oncogene. 9:417-423.
38. Kerbel, R. S., J. Rak, H. Kobayashi, B. St.Croix, and C. H. Graham. 1995. Multicellular resistance: a new paradigm to explain aspects of acquired drug resistance of solid tumors. Cold Spring Harbor Symp. Quant. Biol. Mol. Gen. Cancer. 59:661-672.
39. Kiefer, M. C., M. J. Brauer, V. C. Powers, J. J. Wu, S. R. Umansky, L. D. Tomei, and P. J. Bar. 1995. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature (Lond.). 374:736-739.
40. Kim, W. H., H. W. Schnaper, M. Nomizu, Y. Yamada, and H. K. Kleinman. 1994. Apoptosis in human fibrosarcoma cells is induced by a multimeric synthetic tyr-ile-gly-ser-arg (YIGSR)-containing polypeptide from laminin. Cancer Res. 54:5005-5010.
41. Kinoshita, T., T. Yokota, K. Arai, and A. Miyajima. 1995. Regulation of Bcl-2 expression by oncogenic Ras protein in hematopoietic cells. Oncogene. 10:2207-2210.
42. Kobayashi, H., S. Man, S. J. Kapitain, B. A. Teicher, and R. S. Kerbel. 1993. Acquired multicellular-mediated resistance to alkylating agents in cancer. Proc. Natl. Acad. Sci. USA. 90:3294-3298.
43. Kohl, N. E., S. D. Mosser, S. J. deSolms, E. A. Giuliani, D. L. Pompliano, S. L. Graham, R. L. Smith, E. M. Scolnick, A. Oliff, and J. B. Gibbs. 1993. Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor. Science (Wash. DC). 260:1934-1942.
44. Kohl, N. E., F. R. Wilson, S. D. Mossier, E. Giuliani, S. J. deSolms, M. W. Conner, N. J. Anthony, W. J. Holtz, R. P. Gomez, T. -J. Lee et al. 1994. Protein farnesyltransferase inhibitors block the growth of ras-independent tumors in nude mice. Proc. Natl. Acad. Sci. USA. 91:9141-9145.
45. Kohl, N. E., C. A. Omer, M. W. Conner, N. J. Anthony, J. P. Davide, S. J. deSolms, E. A. Giuliani, R. P. Gomez, S. L. Graham, K. Hamilton et al. 1995. Inhbition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice. Nat. Med. 1:792-797.
46. Laderoute, K. R., B. J. Murphy, S. M. Short, T. D. Grant, A. M. Knapp, and R. M. Sutherland. 1992. Enhancement of transforming growth factor-α synthesis in multicellular tumor spheroids of A431 squamous carcinoma cells. Br. J. Cancer. 65:157-162.
47. Lin, H.-J. L., V. Eviner, G. C. Prendergast, and E. White. 1995. Activated H-ras rescues E1A-induced apoptosis and cooperates with E1A to overcome p53-dependent growth arrest. Mol. Cell. Biol. 15:4536-4544.
48. Linser, P., and A. A. Moscona. 1979. Induction of glutamine synthetase in embryonic neural retina: localization in Muller fibers and dependence on cell interactions. Proc. Natl. Acad. Sci. USA. 76:6476-6480.
49. Lowe, S. W., H. E. Ruley, T. Jacks, and D. E. Housman. 1993. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74: 957-967.
50. Lowe, S. W., S. Bodis, A. McClatchey, L. Remington, H. E. Ruley, D. E. Fisher, D. E. Housman, and T. Jacks. 1994. P53 status and the efficacy of cancer therapy in vivo. Science (Wash. DC). 266:807-810.
51. Magnuson, N. S., T. Beck, H. Vahidi, H. Hahn, U. Smola, and U. R. Rapp. 1994. The raf-1 serine/threonine protein kinase. Semin. Cancer Biol. 5:247-253.
52. Majno, G., and I. Joris. 1995. Apoptosis, oncosis, and necrosis. Am. J. Pathol. 146:3.
53. Mansour, S. J., W. T. Matten, A. S. Hermann, J. M. Candia, S. Rong, K. Fukasawa, G. F. V. Woude, and N. G. Ahn. 1994. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science (Wash. DC). 265:966-970.
54. McDonnell, T. J., R. E. Meyn, and L. E. Robertson. 1995. Implications of apoptotic cell death regulation in cancer therapy. Semin. Cancer Biol. 6:53-60.
55. Meredith, J. E., Jr., B. Fazeli, and M. A. Schwartz. 1993. The extracellular matrix as a cell survival factor. Mol. Biol. Cell. 4:953-961.
56. Minamoto, T., K. Sawaguchi, M. Mai, N. Yamashita, T. Sugimura, and H. Esumi. 1994. Infrequent K-ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas. Cancer Res. 54:2841-2844.
57. Martin, S. J., and D. R. Green. 1995. Apoptosis and cancer: the failure of controls on cell death and cell survival. Crit. Rev. Oncol./Hematology. 18: 137-153.
58. 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc. Natl. Acad. Sci. USA. 91:8856-8860.
59. Oberhammer, F., J. W. Wilson, C. Dive, I. D. Morris, J. A. Hickman, A. E. Wakeling, P. R. Walker, and M. Sikorska. 1994. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO (Eur. Mol. Biol. Organ.) J. 12:3679-3684.
60. Oltvai, Z. N., C. L. Milliman, and S. J. Korsmeyer. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death with a conserved homolog. Cell. 74:609-619.
61. Oren, M. 1992. The involvement of oncogenes and tumor suppressor genes in the control of apoptosis. Cancer Metastasis Rev. 11:141-148.
62. Ormerod, M. G., C. F. O'Neill, D. Robertson, and K. R. Harrap. 1994. Cisplatin induces apoptosis in a human ovarian carcinoma cell line without concomitant internucleosomal degradation of DNA. Exp. Cell Res. 211: 231-237.
63. Parmiter, A. H., and P. C. Nowell. 1993. Cytogenetics of melanocytic tumors. J. Invest. Dermatol. 100:254s-258s.
64. Pietenpol, J. A., N. Papadopoulos, S. Markowitz, J. K. V. Willson, K. W. Kinzler, and B. Vogelstein. 1994. Paradoxical inhibition of solid tumor cell growth by bcl2. Cancer Res. 54:3714-3717.
65. Prendergast, G. C., and J. B. Gibbs. 1993. Pathways of ras function: connections to the actin cytoskeleton. Adv. Cancer Res. 62:19-64.
66. Prendergast, G. C., J. P. Davide, J. de Solms, E. A. Giuliani, S. L. Graham, J. B. Gibbs, A. Oliff, and N. E. Kohl. 1994. Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton. Mol. Cell. Biol. 14:4193-4202.
67. Putman, D. L., D. K. Park, J. S. Rhim, A. F. Steuer, and R. C. Ting. 1977. Correlation of cellular aggregation of transformed cells with their growth in soft agar and tumorigenic potential. Proc. Soc. Exp. Biol. Med. 155: 487-494.
68. Quaroni, A., and K. J. Isselbacher. 1981. Cytotoxic effects and metabolism of Benzo[a]pyrene and 7,12-Dimethylbenz[a]anthracene in duodenal and ileal epithelial cell cultures. J. Natl. Canc. Inst. 67:1353-1362.
69. Raff, M. 1992. Social controls on cell survival and cell death. Nature (Lond.). 356:397-400.
70. Rak, J. W., and R. S. Kerbel. 1993. Growth advantage ("clonal dominance") of metastatically-competent tumor cell variants expressed under selective two or three-dimensional tissue culture conditions. In Vitro Cell. Dev. Biol. 29A:742-748.
71. Rak, J., Y. Mitsuhashi, L. Bayko, J. Filmus, T. Sasazuki, and R. S. Kerbel. 1995. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res. 55: 4575-4580.
72. Re, F., A. Zanetti, M. Sironi, N. Polentarutti, L. Lanfrancone, E. Dejana, and F. Colotta. 1994. Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. J. Cell Biol. 127: 537-546.
73. Reed, J. C. 1994. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124:1-6.
74. Rofstad, E. K., A. Wahl, C. Davies, and T. Brustad. 1986. Growth characteristics of human melanoma multicellular spheroids in liquid-overlay culture: comparisons with the parent tumour xenografts. Cell Tissue Kinet. 19:205-216.
75. Ruoslahti, E., and J. C. Reed. 1994. Anchorage dependence, integrins, and apoptosis. Cell. 77:477-478.
76. Sakai, N., Y. Ogiso, H. Fujita, H. Watari, T. Koike, and N. Kuzumaki. 1994. Induction of apoptosis by a dominant negative H-RAS mutant (116Y) in K562 cells. Exp. Cell Res. 215:131-136.
77. Schulze-Osthoff, K., H. Walczak, W. Droge, and P. H. Krammer. 1994. Cell nucleus and DNA fragmentation are not required for apoptosis. J. Cell Biol. 127:15-20.
78. Shirasawa, S., M. Furuse, N. Yokoyama, and T. Sasazuki. 1993. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science (Wash. DC). 260:85-88.
79. Singhvi, R., A. Kumar, G. P. Lopez, G. N. Stephanopoulos, D. I. C. Wang, G. M. Whitesides, and D. E. Ingber. 1994. Engineering cell shape and function. Science (Wash. DC). 264:696-698.
80. Stewart, B. W. 1994. Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators. J. Natl. Canc. Inst. 86:1286-1296.
81. Sutherland, R. M. 1988. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science (Wash. DC). 240:177-184.
82. Symonds, H., L. Krail, L. Remington, M. Saenz-Robles, S. Lowe, T. Jacks, and T. Van Dyke. 1994. p53-dependent apoptosis suppresses tumor growth progression in vivo. Cell. 78:703-711.
83. Takayama, S., T. Sato, S. Krajewski, K. Kochel, S. Irie, J. A. Millan, and J. C. Reed. 1995. Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell. 80:279-284.
84. Tanaka, N., M. Ishihara, M. Kitagawa, H. Harada, T. Kimura, T. Matusuyama, M. S. Lamphier, S. Aizawa, T. W. Mak, and T. Taniguchi. 1994. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell. 77:829-839.
85. Theodorescu, D., C. Sheehan, and R. S. Kerbel. 1993. Tumor cells grown as monolayers or multicellular spheroids indicate autoregulation of TGF-β gene expression is dependent on tissue architecture. In Vitro Cell. Dev. Biol. 29:105-108.
86. Vardimon, L., L. Fox, L. Degenstein, and A. A. Moscona. 1988. Cell contacts are required for the induction by cortisol of glutamine synthetase gene transcription in the retina. Proc. Natl. Acad. Sci. USA. 85:5981-5985.
87. Wyllie, A. H. 1992. Apoptosis: the 1992 Frank Rose Memorial Lecture. Br. J. Cancer. 67:205-208.
88. Wyllie, A. H., K. A. Rose, R. G. Morris, C. M. Steel, E. Foster, and D. A. Spandidos. 1987. Rodent fibroblast tumours expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression. Br. J. Cancer. 56:251-259.
89. L and Bcl-2, displaces Bax and promotes cell death. Cell. 80:285-291.
90. Zhang, Z., K. Vuori, J. C. Reed, and E. Ruoslahti. 1995. The α5β1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc. Natl. Acad. Sci. USA. 92:6161-6165.
91. Zhao, J., and R. N. Buick. 1993. Relationship of levels and kinetics of H-ras expression to transformed phenotype and loss of TGF-β-mediated growth regulation in intestinal epithelial cells. Exp. Cell Res. 204:82-87.